Showing results (221-230 of 350) with videos related to

Sort By:
Pageof 35
Medical and Pediatric Oncology|January 1, 1981
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancerA Goldhirsch, R A Joss, F Cavalli, et al.
Helvetica Chirurgica Acta|June 1, 1989
[Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma]M Rentsch, T Cerny, J Richner, et al.
Schweizerische Medizinische Wochenschrift|October 24, 1981
[Nausea and vomiting during chemotherapy of malignant tumors]R Joss, R Galeazzi, A Gervasi, et al.
Schweizerische Medizinische Wochenschrift|May 29, 1976
[First therapeutic experience with cis-platinum(II)diamindichloride (NSC 119875) in metastasizing ovarian and testicular carcinoma]F Cavalli, R W Sonntag, H J Ryssel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular transportM R Block, B S Glick, C A Wilcox, et al.
The EMBO Journal|July 1, 1993
beta'-COP, a novel subunit of coatomerG Stenbeck, C Harter, A Brecht, et al.
European Journal of Biochemistry|August 1, 1996
Receptor-induced translocation of activated guanine-nucleotide-binding protein alpha i subunits to the cytoskeleton in myeloid differentiated human leukemia (HL-60) cellsT Wieland, D Meyer zu Heringdorf, R A Schulze, et al.
Cell Reports|January 4, 2019
Proteomic Profiling of Mammalian COPII and COPI VesiclesFrank Adolf, Manuel Rhiel, Bernd Hessling, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
A phase I trial of marcellomycin with a weekly dose scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Investigational New Drugs|January 1, 1984
A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Pageof 35